Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the Audited Financial Results ....
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences Ltd has informed the stock exchanges that its Board of Directors will meet on Friday, May 30, 2025, to consider and approve the Audited Financial Results for the financial year 2024-25, along with the Financial Statements and related matters. The notice has been filed under SEBI Listing Regulations and signed by the Company Secretary on May 27, 2025. This is a routine advance intimation required before announcing full-year audited results. No actual financial numbers, dividend declaration, or auditor qualifications are mentioned in this filing.
No immediate impact on shareholders or stock price from this notice alone, as it is a procedural filing. Investors should watch the actual results announcement on or after May 30, 2025 for any meaningful price movement.